Description
The Diploma in Regulatory Affairs is a comprehensive online eLearning program designed to develop knowledge of pharmaceutical regulations, regulatory processes and documentation across the product-development lifecycle.
The program explores regulatory frameworks and requirements across major markets including the United States, European Union, Japan and India, along with regulations governing clinical trials and pharmaceutical development.
Learners develop knowledge of regulatory submissions and documentation including the Common Technical Document (CTD), electronic Common Technical Document (eCTD), Investigational New Drug (IND) applications, New Drug Applications (NDAs), and Chemistry, Manufacturing and Controls (CMC) information.
The curriculum also introduces regulatory considerations for medical devices, veterinary products, biosimilars and biopharmaceuticals before progressing to regulatory strategic planning and corporate communications.
The program is delivered through flexible, self-paced eLearning with multimedia tutorials, recorded learning content, quizzes and assessments.
Program at a Glance
18 Modules | 55 Chapters | 56 Quizzes
3 Months | Self-Paced eLearning | Certificate on Completion
What You’ll Learn
- Understand the role of Regulatory Affairs across pharmaceutical development
- Explore regulatory frameworks in the United States, European Union, Japan and India
- Understand regulatory requirements governing clinical trials
- Develop familiarity with major regulatory authorities and their responsibilities
- Understand the structure and principles of CTD and eCTD submissions
- Explore IND and NDA requirements
- Develop knowledge of Chemistry, Manufacturing and Controls (CMC)
- Understand regulatory considerations during preclinical and clinical development
- Explore regulatory processes for medical devices and veterinary products
- Develop knowledge of biosimilar and biopharmaceutical regulatory requirements
- Understand regulatory strategic planning
- Explore regulatory authority interactions and corporate communications
Who Is This Program For?
- Students and graduates interested in pharmaceutical Regulatory Affairs
- Pharmacy, pharmaceutical sciences, life sciences, medical and healthcare graduates
- Clinical research professionals seeking broader regulatory knowledge
- Professionals involved in clinical trial or regulatory documentation
- Pharmaceutical professionals seeking structured learning in global regulatory requirements
- Learners interested in drug-development and regulatory submission processes
Regulatory Affairs Across the Product Lifecycle
Regulatory Affairs supports pharmaceutical development from early development and clinical research through regulatory submission, approval and post-marketing activities.
This program introduces the regulatory requirements, documentation and strategic considerations involved across different stages of product development while exploring how requirements vary across major regulatory markets.
Learn More About Regulatory Affairs
New to the field? Explore our introductory resource to understand the role of Regulatory Affairs in pharmaceutical development, regulatory submissions and interactions with regulatory authorities.
What is Regulatory Affairs?
Curriculum
The curriculum progresses from regulatory foundations and country-specific frameworks through preclinical and clinical development requirements, regulatory submissions, specialized product areas and regulatory strategy.
The program covers regulatory requirements across multiple markets while introducing the documentation and strategic considerations involved throughout pharmaceutical development.
Module 1 – General Introduction
- Pharmaceutical & CR – Industry Overview
- Introduction to Clinical Research
- Stakeholders and Roles in Clinical Research
- History and Milestones in Clinical Research
- Principles of Good Clinical Practice
- Technologies in Clinical Trial Management
- Overview of Clinical Research Regulatory Bodies
Module 2 – Introduction to the Judicial System in India
- Introduction to Medical Ethics, Medical Malpractice
- Overview of Judicial System in India
- Legitimacy and Paternity
- Privileged Communication and Professional Secrets
Module 3 – Drugs and Cosmetic Act and Rules
- Introduction, Aims and Objectives, Definitions
- Schedules to Drug Rules
- Import, Manufacture and Sale of Drugs
- Labeling and Packaging of Drugs
Module 4 – Schedule Y
- Introduction, Amendments to Schedule Y
- Clinical Trials
- Studies in Special Population, Post Marketing Surveillance and Special Studies
- Appendices
Module 5 – Indian Regulations Governing Clinical Trials
- Regulatory Authorities in India
- Guidelines and important provisions
- Indian Regulatory Approval Process and approval timelines
Module 6 – Regulatory Regime in US
- Responsibilities of US FDA
- FDA Centers
- Code of Federal Regulations
- FDA guidelines for industry
Module 7 – European Medicines Agency (EMEA)
- Introduction, Roles and Responsibilities of EMEA
- Committees of EMEA
- EU Clinical Directives
- EUDRA CT
Module 8 – Regulations in Japan
- Organization and Function of MHLW (JAPAN)
- Pharmaceutical Laws and Regulations in Japan
- Drug Development in Japan
Module 9 – In-Vitro and In-Vivo Pre-clinical studies
- ICH Safety Guidelines related to Carcinogenicity, Genotoxicity, Reprotoxicity
- ICH safety guidelines related to pharmacology and immunotoxicology studies
Module 10 – Efficacy Topics related to Clinical Studies
- Clinical Safety
- Dose Response Studies
- Clinical Evaluation
Module 11 – Common Technical Document (CTD)
- General principles of CTD
- Modules with Diagrammatic representation
- eCTD
Module 12 – IND and NDA Requirements
- IND and NDA applications in U.S
- IND and NDA Applications in India
Module 13 – CMC Information
- CMC for Phase I
- CMC for Phase II and III
Module 14 – Overview of GHTF
- Organization
- Study Groups and Documents
Module 15 – Regulatory Processes for Medical Devices and Veterinary Products
- U.S Scenario
- Indian Scenario
Module 16 – Biosimilars EMEA Guidance and Regulations
- Guidelines and Applications of Biosimilars
- Specific Guidelines
Module 17 – Biopharmaceutical Indian Regulations and Guidelines
- Regulatory Bodies
- Guidelines for Pre-Clinical and Clinical studies
Module 18 – Regulatory Strategic Planning, Interfacing and Corporate Communications
- Regulatory Strategic Planning
- Corporate Communications
Course Completion
- Final Assessment
- Course Certification
Certification
Upon successful completion of the program and final assessment, learners receive a ClinSkill Certificate of Completion.
Duration
The program duration is 3 months, with flexible, self-paced access to the online learning portal for the duration of the program.
Reviews
There are no reviews yet.